Skip to Content
Merck
All Photos(1)

Documents

EHU067821

Sigma-Aldrich

MISSION® esiRNA

targeting human GTSE1

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GACAGGGGTTCTCCTCCTTCCCGTGTGCCTCAGGCACTTAACTTTTCTCCAGAGGAAAGCGATTCTACTTTCTCCAAAAGTACTGCCACAGAAGTAGCTCGGGAGGAAGCCAAGCCGGGTGGAGATGCAGCCCCTAGTGAGGCTCTTCTTGTAGATATCAAACTGGAACCACTCGCGGTCACTCCAGATGCTGCAAGCCAGCCCCTCATTGACCTTCCTCTCATCGACTTCTGCGATACCCCAGAAGCACACGTGGCTGTAGGATCTGAAAGCAGGCCTCTGATCGACCTCATGACAAACACTCCAGACATGAATAAAAATGTGGCCAAACCTTCACCGGTGGTGGGACAGCTCATAGACCTGAGCTCCCCTCTGATCCAGCTGAGCCCTGAGGCTGACAAGGAGAACGTGGATTCCCCACTCCTCAAGTTCTAAGCCGAACCAAATCCTTTGCCTTGAAA

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xiaojuan Wu et al.
Scientific reports, 7(1), 5129-5129 (2017-07-13)
G2 and S phase-expressed-1 (GTSE1) regulates G1/S cell cycle transition. It was recently reported to be overexpressed in certain human cancers, but its significance and mechanism(s) in hepatocellular carcinoma (HCC) remain unknown. Here, we showed preferential GTSE1 upregulation in human
Vinod Vijay Subhash et al.
BMC cancer, 15, 550-550 (2015-07-26)
Platinum based therapy is commonly used in the treatment of advanced gastric cancer. However, resistance to chemotherapy is a major challenge that causes marked variation in individual response rate and survival rate. In this study, we aimed to identify the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service